Identifying Small Molecule Inhibitors of SLC38A2/SNAT2 to Treat Pancreatic Cancer Drug Discovery Award (2022-Present) Alec Kimmelman, MD, PhD, New York University; Seth Parker, PhD, University of British Columbia Read More
Developing CDK11 Inhibition as a Novel Anti-Cancer Strategy Drug Discovery Award (2022-Present) Jason Sheltzer PhD, Yale University; Jane Endicott, PhD, Newcastle University Read More
The Microbiome of Glioblastoma Multiforme and the Normal Brain: Characterization and Translational Opportunities IN PARTNERSHIP WITH THE ISRAEL CANCER RESEARCH FUND (2022-PRESENT) Ravid Straussman, MD, PhD, Weizmann Institute of Science, Israel Read More
Genomic and Epidemiological Characterization of Early-Age Onset Colorectal Cancers THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER - MARK FOUNDATION POSTDOCTORAL FELLOW (2022-PRESENT) Wellington Oliveira dos Santos, PhD, The International Agency for Research on Cancer Read More
NexTGen: Next Generation T Cell Therapies for Childhood Cancers CANCER GRAND CHALLENGES AWARD, IN PARTNERSHIP WITH CANCER RESEARCH UK AND THE NATIONAL CANCER INSTITUTE (2022-Present) Catherine Bollard, MBChB, MD, Children’s National Medical Center; Martin Pule, MD, University College London Read More
Chemical Genetic Dissection of Oncoenhancers in Multiple Myeloma IN PARTNERSHIP WITH GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH (2022-PRESENT) Christopher Ott, PhD, Massachusetts General Hospital Read More
